Results 131 to 140 of about 19,877 (193)
Some of the next articles are maybe not open access.

Antiphospholipid Antibodies and Reproduction: The Antiphospholipid Antibody Syndrome

American Journal of Reproductive Immunology, 1999
In women who have a diagnosis of APS (both clinical and laboratory criteria) the chance for successful pregnancy is reduced. In these cases, treatment appears to be a clear option, particularly in the case of prior thromboembolic events. The current preference of treatment for women with RPL and aPL antibodies is subcutaneous heparin and aspirin.
William H Kutteh   +2 more
exaly   +3 more sources

Antiphospholipid antibodies and the antiphospholipid antibody syndrome

Drugs of Today, 2000
The antiphospholipid antibody syndrome is a multisystem disorder characterized by persistently elevated antiphospholipid antibodies and/or arterial or venous thrombosis, thrombocytopenia and recurrent spontaneous abortion. Anticardiolipin antibodies and the lupus anticoagulant are different classes of antiphospholipid antibodies associated with this ...
G T, Nahass, S L, Jensen
openaire   +2 more sources

Antiphospholipid antibodies

Australian and New Zealand Journal of Medicine, 1991
This review has focused on some recent developments which have begun to define the immunologic specificity of aPL antibodies. These studies have revealed that these immunoglobulins are more complex than has been realised to date and, more importantly, they offer new approaches to investigate how the prothrombotic diathesis associated with aPL ...
H P, McNeil, S A, Krilis
openaire   +2 more sources

Antiphospholipid syndrome, antiphospholipid antibodies, and stroke

International Journal of Stroke, 2023
Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disease with heterogeneous clinicopathological manifestations and is a well-established cause of acute ischemic stroke (AIS) and transient ischemic attack (TIA), particularly in younger patients.
Prabal Mittal   +5 more
openaire   +2 more sources

The antiphospholipid antibodies

Haematologia, 2001
Antiphospholipid antibodies (APLAs) are a group of autoantibodies directed against certain phospholipids, or their protein cofactors. Assay of APLAs is important because their interaction with anionic phospholipid-protein cofactors can generate a syndrome of hypercoagulability associated with a wide variety of thromboembolic events.
Cristina, Tanaseanu   +3 more
openaire   +2 more sources

Antiphospholipid antibodies

Annals of Neurology, 1989
AbstractLupus anticoagulants and anticardiolipin antibodies, known collectively as antiphospholipid antibodies, are becoming established as markers for increased risk of thrombosis, including ischemic cerebrovascular disease. In this brief review, we highlight evidence for an against a pathogenetic role of these antibodies in ischemic brain disease and
S R, Levine, K M, Welch
openaire   +2 more sources

Antiphospholipid antibodies and antiphospholipid syndrome

Current Opinion in Rheumatology, 1995
More than a decade has gone by since the detailed clinical description of antiphospholipid syndrome (APS). Thrombosis, the main complication of the syndrome, can affect vessels of all sizes; the consistent histopathologic lesion is a bland thrombus without inflammation.
M A, Khamashta, G R, Hughes
openaire   +2 more sources

Antiphospholipid antibodies and the antiphospholipid syndrome

Springer Seminars in Immunopathology, 1994
The study of aPL antibodies and the APS has appealed to large numbers of investigators over the last decade. This accounts, in part, for the great degree of apparently contradictory data being published. What seems certain is that these antibodies are associated with thrombosis and recurrent pregnancy loss, and animal data suggest a direct role in ...
E N, Harris, S S, Pierangeli
openaire   +2 more sources

Home - About - Disclaimer - Privacy